June 17 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* NUVO PHARMACEUTICALS INC - CONTINUES TO ASSESS ITS OPTIONS REGARDING VIMOVO PATENTS
* NUVO PHARMACEUTICALS INC - COMPANY'S REVENUES FROM SALES OF VIMOVO OUTSIDE OF U.S. ARE UNAFFECTED BY ANY RULING MADE BY U.S. COURTS.
* NUVO PHARMACEUTICALS INC - NUVO CONTINUES TO BELIEVE THAT '907 AND '285 PATENTS CONTAIN VALID CLAIMS.
* NUVO PHARMACEUTICALS INC - NUVO'S CANADIAN COMMERCIAL BUSINESS CONTINUES TO PERFORM AS EXPECTED.